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Abstract 
Marek’s disease is still a major problem among Egyptian poultry flocks, despite the intensive 
vaccination programs against the disease. This study was conducted to investigate the prevalence 
of MDV infection among forty-four flocks of breeders and layers with ages ranged from 4-20 
months. Feather follicle specimens were collected during 2012-2015 from 44 vaccinated chicken 
flocks showing emaciation and visceral tumors. The samples were tested by PCR using three 
pairs of primers. Nineteen flocks were positive for MDV using primers targeting the UL 19 gene 
with a percentage of 43.2%. Three flocks were shown to be positive by primers targeting the meq 
and 132 bp tandem repeat genes with a percentage of 6.8%. Inoculation of duck embryo 
fibroblast (DEF) and chick embryo fibroblast (CEF) showed CPE in the form of plaques 
formation within 5-14 days post inoculation. Sequencing of meq and 132 tandem repeat genes of 
the 3 samples revealed that the isolated strains exhibited 99% homology with the very virulent 
European, Chinese, American, Indian and Egyptian MDV isolates. In conclusion, although the 
availability of MDV vaccines especially HVT vaccine which is used in the examined flocks in 
the present study, the disease was recorded. Thus, indicating that HVT vaccines are unable to 
protect completely against more virulent strains. Therefore, there is a need to develop a new 
strategy and types of vaccination to be able to protect against new strains of virus. 
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Introduction 
Marek’s disease (MD) is one of the most 
economically devastating infectious diseases 
of poultry caused by the highly infectious, cell 
associated MD virus (MDV) [1]. The MDV 
belongs to the genus Mardivirus, subfamily 
alphaherpesvirinae and there are three 
serotypes of MDV: MDV-1 (e.g., RB-1B, 
Md5, GA, and CVI988) able to induce disease 
in chickens, MDV-2 (e.g., SB-1 and HPRS24) 
that is considered non-pathogenic and used as 
vaccines, and MDV-3, which is also called 
herpesvirus of turkeys (HVT; e.g., FC126) that 
also considered as non-pathogenic and used as 
vaccines. Recently, serotype-1 is named as 
gallid herpesvirus II, serotype -2 as gallid 
herpesvirus III, and serotype -3 (HVT) as 
meleagrid herpes virus 1[1]. 
During early cytolytic infection, replication 
of the virus occurs in B and T lymphocytes 
then a latent infection is established in T 
lymphocytes, which may become transformed 
and form lymphomatous lesions in the visceral 
organs, peripheral nerves and skin [2]. The 
virus is capable of inducing many disease 
syndromes in chickens such as lymphomatosis 
in nerves, skin, eye, and visceral organs; 
lymph degeneration in the immune system; 
transient paralysis in the central nervous 
system; and atherosclerosis in the blood 
vessels [1]. Infection with the virulent MDV 
strains and subsequent vaccine breaks can still 
occur despite the intensive vaccination 
strategies with the widely used CVI 988 
vaccine [3]. The vaccine breaks may be 
attributed to many factors such as increased 
virulence of MDV strains over the last four 
decades [4]. In addition, presence of 
immunosuppressive agents or the difficulties 
associated with the vaccine handling due to its 
cell-associated form may also cause vaccine 
breaks [5]. Polymerase Chain Reaction (PCR) 
is a suitable technique to determine serotype 
specificity and to differentiate between 
vaccinal and wild strains of MDV serotype-1 
[6-9]. The aim of this study was the isolation 
and molecular identification of MDV strains 
from MDV-vaccinated layer and breeder 
chicken flocks, Egypt. 
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Table 1: Isolates of MDV published on GenBank used in comparison and phylogenetic analysis of meq gene 
No Isolate 0rigin Accession No 
1 Gallid herpesvirus 2 isolate LDH-2483 Meq oncoprotein (Meq) gene India KF895031.1 
2 Gallid herpesvirus 2 isolate ATE, Meq gene, complete cds USA AY571784.1 
3 Gallid herpesvirus 2 isolate MDJ4⁄1303, MEQ, complete cds China KP888850.1 
4 Gallid herpesvirus 2 isolate HL⁄1111, complete cds China KP888821.1 
5 Gallid herpesvirus 2 isolate 04 meq protein,Meq gene, partial cds India KT246103.1 
6 Gallid herpesvirus 2 isolate LDH-2614, Meq gene India KF895032.1 
7 Gallid herpesvirus 2 isolate Egypt 2 Meq gene, partial cds Egypt JX467679.1 
8 Gallid herpesvirus 2 isolate Egypt_4 Meq gene, partial cds Egypt KC161220.1 
9 Gallid herpesvirus 2 isolate DL⁄1311 MEQ gene China KP888845.1 
10 Gallid herpesvirus 2 isolate DL⁄1112 MEQ gene China KP888818.1 
11 Gallid herpesvirus 2 isolate LDH(JL⁄07⁄I), Meq gene China HQ658614.1 
12 Gallid herpesvirus 2 strain 617 A meq oncoprotein USA AY362712.1 
13 Gallid herpesvirus 2 isolate YC⁄1210 MEQ gene China KP888840.1 
14 Gallid herpesvirus 2 strain N MEQ (meq) mRNA China AF493557.1 
15 Gallid herpesvirus 2 isolate CF⁄1312 MEQ gen China KP888844.1 
16 Gallid herpesvirus 2 isolate HT⁄1207 MEQ gene China KP888837.1 
17 Gallid herpesvirus 2 isolate LLY MEQ gene China KP888822.1 
18 Gallid herpesvirus 2 strain YL 040920 Meq gene China DQ174459.1 
19 Gallid herpesvirus 2 isolate SJZ⁄1208 meq gene China KP888828.1 
20 Gallid herpesvirus 2 isolate LNCY⁄1205 Meq gene China KP888835.1 
21 Gallid herpesvirus 2 isolate FY⁄1303 Meq gene China KP888847.1 
22 Gallid herpesvirus 2 isolate NT⁄1211 MEQ gene China KP888836.1 
23 Gallid herpesvirus 2 isolate QD⁄1311 meq gene China KP888856.1 
24 Gallid herpesvirus 2 isolate SD2012-1 MEQ gene China KC511815.1 
 
Material and Methods 
Sample collection 
 The examined samples were collected 
during 2012-2015 from 44 vaccinated chicken 
flocks located in four different Governorates in 
the Egyptian Delta: Sharkia (5 flocks), 
Dakahlia (25 flocks), Damietta (10 flocks) and 
Ismalia (4 flocks). Two to three birds per flock 
were sampled according to availability. The 
samples collected from the wing of each bird, 
consisted of three or four feather tips. For 
preparation of feather tips, feathers were 
pulled from all major feather tracts, and 3-5 
mm parts of the tips were cut with scissor, 
diluted 1:5 (W/V) with sucrose-phosphate-
glutamine-albumin buffer containing sodium 
ethylene diaminetetraacetic acid (SPGA-
EDTA) buffer, and sonicated for 2-3 min. 
From each flock, pooled feathers from the 
examined birds were used for PCR. 
Molecular identification 
Total DNA was extracted using QIAamp 
DNA Mini Kit (QIAGEN). The procedures 
were carried out according to the 
manufacturer’s instructions. Three pairs of 
primers specific for UL19, meq gene and 132 
bp tandem repeat genes were used. The 
sequences of primers are: UL19: F (5΄-CCC 
GAT ATT ATC ATT TCA CC-3΄) R (5΄-CTC 
GCA TTA TTA TCT GAA GT-3΄) producing 
521 bp [10], meq: F (5΄- GCA CTC TAG AGT 
GTA AAG AGA TGT CTC AG-3΄) R (5΄- 
TAA CTC GAG GAG AAG AAA CAT GGG 
GCA TAG-3΄) producing 1060 bp and 132bp 
tandem repeat: F (5΄- TAC TTC CTA TAT 
ATA GAT TGA GAC GT-3΄) R (5΄- GAG 
ATC CTC GTA AGG TGT AAT ATA-3΄) 
producing 434 bp [11]. 
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Table 2: Isolates of MDV published on GeneBank used in comparison and phylogenetic analysis of 132 bp 
tandem repeat gene 
No Isolate 0rigin Accession No 
1 Gallid herpesvirus 2 isolate CVI988, internal repeat long region, partial cds USA DQ534538.1 
2 Gallid herpesvirus 2 isolate CU-2, internal repeat long region, partial cds USA DQ534537.1 
3 Gallid herpesvirus 2 isolate R2/23 internal repeat long region, partial cds USA DQ534540.1 
4 Gallid herpesvirus 2 isolate 571 internal repeat long region, partial cds USA DQ534531.1 
5 Marek’s Disease Virus (Strain BC-1), tandem direct repeat, from IR-L 
region 
USA M12619.1 
6 Gallid herpesvirus 2 isolate RB1B, internal repeat long region, partial cds USA DQ534541.1 
7 Marek’s Disease Virus BamI-H fragment DNA from MSB-1 USA M26392.1 
8 Gallid herpesvirus 2 isolate CVI988-BP5 internal repeat long region, partial 
cds 
USA DQ534536.1 
9 Gallid herpesvirus 1 DNA, Tumor associated region USA D10488.1 
10 Gallid herpesvirus 2 isolate RM.1 internal repeat long region, partial cds USA DQ534542.1 
11 Gallid herpesvirus 2 isolate JM\102 W internal repeat long region, partial 
cds 
USA DQ534539.1 
12 Gallid herpesvirus 2 isolate 549 a internal repeat long region, partial cds USA DQ534530.1 
13 Gallid herpesvirus 2 isolate 686 internal repeat long region, partial cds USA DQ534535.1 
14 Gallid herpesvirus 2 isolate 595 internal repeat long region, partial cds USA DQ534533.1 
15 Gallid herpesvirus 2 strain 648 a isolate p61 USA JQ809692.1 
16 Gallid herpesvirus 2 strain CVI988, complete cds USA DQ530348.1 
17 Gallid herpesvirus 2 strain RB-1B, complete cds USA EF523390.1 
18 Gallid herpesvirus 2 strain WK-2014 non-coding repeated region, complete 
cds 
Poland KP840550.1 
19 Gallid herpesvirus 2 isolate LMS, complete cds China JQ314003.1 
20 Gallid herpesvirus 2 virus, complte cds USA AF147806.2 
21 Gallid herpesvirus 2 isolate GX0101, complete cds China JX488666.1 
22 Gallid herpesvirus 2 isolate Md5, complete cds USA AF243438.1 
23 MDV-Anand3 BamI-H fragment repeat region, partial cds India DQ296003.1 
 
PCR amplification of MDV genes 
The amplification was carried out in 50 µL 
reaction volume containing 5 μL of PCR 
buffer (500 mM KCL, 100 μM Tris HCL, 15 
μM Triton X-100), 2 μL of total DNA (1 
μg/mL), 2 μL of each primer, 2 μL of dNTP 
(0.2 Μm), 2 μL of MgCL2 (2mM) , 1 μL of 
thermostable polymerase DNA and 34 uL of 
sterile water.  
The following conditions were applied for 
UL19 PCR: 35 cycles with initial denaturation 
at 94°C for 5 min, denaturation at 94°C for 40 
sec, annealing at 52°C for 1 min, elongation at 
72°C for 65 sec and final elongation at 72°C 
for 7 min [10]. While, the conditions applied 
for meq PCR were 35 cycles with initial 
denaturation at 94°C for 5 min, denaturation at 
94°C for 40 sec, annealing at 60.2°C for 1 
min, elongation at 72°C for 65 sec and final 
elongation at 72°C for 7 min. Finally, the 
conditions for 132 bp PCR were 35 cycles 
with initial denaturation at 94°C for 5 min, 
denaturation at 94°C for 40 sec, annealing at 
47°C for 1 min, elongation at 72° C for 65 sec 
and final elongation at 72°C for 7 min [11]. 
PCR products were visualized by agarose gel 
electrophoresis in 1.5% agarose gel, stained 
with Ethidium bromide and photographed 
under ultraviolet light. 
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Figure 1: (A): Showing gel electrophoresis of 521bp products amplified by PCR using UL19 primer. Lane M= 
100bp ladder, Lane 1 – 3 represent samples, samples 1,2,3 are positive samples which represent flock No. 9, 
10 and 11. (B): Showing gel electrophoresis of 434 bp products amplified by PCR using 132 bp tandem repeat 
primer. Lane M= 100bp ladder, Lane 1 – 8 represent samples, samples 1, 4 and 8 are positive samples 
represent flock No. 24, 25 and 42. (C): Showing gel electrophoresis of 1.06 bp products amplified by PCR 
using meq primer. Lane M= 100bp ladder, Lane 1-2 represent samples. Samples 1,2 are positive.   (D): CPE 
of MDV on CEF (5-8dpi).   (E): CPE of MDV on DEF (13 dpi). 
Gene Sequencing of meq and 132 bp tandem 
repeat genes  
The PCR products of meq and 132 bp 
tandem repeat genes (two, each) were purified 
from agarose gel using QIAquick® PCR 
Purification kit (Qiagen), and then sequenced 
by Sanger dideoxy sequencing method (Sigma 
Company). The sequences were submitted 
to the GenBank and the accession numbers 
KU229905 -KU229906 -KU229907 -
KU229908 were provided. 
Sequence and phylogenetic analysis 
Alignment of the sequences was carried out 
by the Clustal W method using MegAlign 
module of DNA star software (Lasergene, 
version 7.2, DNA STAR, WI, USA). The 
nucleotide sequences were compared with 
vvMDV sequences available on the GenBank 
(Tables 1,2). Construction of the phylogenetic 
tree was performed using neighbor-joining 
method in MEGA 5 (www.megasoftware.net) 
and the tree topography was evaluated by 1000 
bootstrap analysis. 
Isolation of MDV on cell culture 
 Duck embryo and Chick embryo 
fibroblasts were prepared according to Schat 
and Purchase [12]. Three positive samples by 
meq and 132 bp tandem repeat were inoculated 
into primary duck embryo fibroblast (DEF) 
prepared from 11-14 days old embryos and 
then they were incubated at 37°C with 5% CO2 
for 7-14 days. The supernatant of DEF was 
then used to inoculate chick embryo fibroblast 
(CEF) prepared from 9-11 days old embryos, 
and incubated at 37°C with 5% CO2 for 7-14 
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days. The inoculated CEF was observed daily 
for cytopathic effect (CPE).  
Results 
Clinical examination and necropsy 
 The samples were obtained from chickens 
between 120 and 450 days of age. In the 44 
examined flocks, the chicken necropsy 
revealed visceral tumors that were mainly in 
liver, spleen and gonads in the form of diffuse 
or localized lymphomas. 
Detection of MDV genome by PCR  
Out of 44 pooled samples, only 19 (43.2 %) 
were positive by primer sets targeting the 
UL19 gene (Figure 1A). Only 3 out of the 
positive samples by UL19 PCR were positive 
for 132 bp tandem repeats and meq PCR 
(Figures 1B and 1C). 
Sequence and phylogenetic analysis  
Comparison of the nucleic acid sequences 
of meq and tandem repeat genes of the isolates 
were aligned together with other MDV strains 
on Gene Bank. The results presented that the 
isolates obtained in the current study are very 
virulent MDV strains and with high similarity 
(99%) with very virulent Chinese, Indian, 
European ATE and Egyptian strains (Figures 2 
,3). 
 
 
Figure 2: Phylogenetic analysis of meq gene nucleotide sequences of vvMDV isolated from Egyptian poultry 
flocks and other sequences available on GeneBank. 
Isolation of MDV on cell culture 
The MDV isolation trials revealed variable 
degrees of CPE in form of plaques formation 
in the three positive samples.  Infected cell 
cultures developed discrete focal lesions, 
which consisted of clusters of rounded, 
refractile cells (foci or plaques) (5- 14 days 
post infection). The CPE on DEF appeared 13 
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dpi (Figure 1D), while on CEF appeared 
within 5-8 dpi (Figure 1E).  
Discussion 
In spite of intensive vaccination strategy 
against MDV using HVT or HVT+CVI988 in 
chicks at one day of age, the flocks are still 
having cases of neural and or visceral tumors 
[13,14]. This may be due to vaccination failure 
which is caused by several reasons mainly the 
emergence of new more virulent strains of the 
virus. 
Out of 44 specimens, 19 (43%) were 
positive for MDV serotypes (1,2 and 3) using 
UL19 primers that gave 521 bp amplicon. 
Similarly, Ottiger [10] stated that UL19 primer 
is helpful in detecting any of the three MDV 
serotypes [10]. There is a close correlation 
between the number of 132 bp sequence 
repeats and pathogenicity and in turn 
oncogenicity of the strains, therefore, this 
sequence can be used for differentiation 
between vaccinal and field strains [7,15]. The 
19 MDV 19 isolates were tested using 132 bp 
tandem repeats primer, 3 positive oncogenic 
viruses of serotype 1 were confirmed by 
production of 434 bp amplicon. These results 
were supported by previous studies [7,15] 
reported that only one product is observed in 
the case of oncogenic (serotype 1) field strains, 
while, multiple copies of 132 bp repeats were 
identified in vaccine CVI 988 Rispens 
(serotype 1). In addition, in the serotype 3 
vaccinal strain (HVT) virus, no bands were 
recorded. These findings could be attributed to 
an increase in the number of copies of 132 bp 
repeats within the BamHI-H region of IR 
(inverted repeats) as a result of attenuation by 
cell culture passage for vaccine preparation 
[16].  
 
 
 
Figure 3: Phylogenetic analysis of 132bp tandem repeat gene nucleotide sequences of vvMDV isolated from 
Egyptian poultry flocks and other sequences available on GenBank. 
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Further confirmation of the oncogenicity of 
the three MDV-1 isolates was conducted by 
the amplification of the meq gene. The three 
isolates produced 1060 bp amplicon. Chang et 
al. [17] explained that during the attenuation, 
the 1.06 kb sequence is inserted into the gene, 
resulting in an additional PCR product (L-
meq) in the case of vaccine strains [17]. 
Therefore, these primers were used in the 
present study to differentiate vaccinal and field 
strains of MDV serotype 1. However, the 
serotype 3 vaccinal strain (HVT) produced no 
bands by these primers. Krol et al. [11] 
reported similar findings.  
In the current study, sequence analysis of 
the PCR products of the three oncogenic field 
viruses and alignment of the obtained 
sequences of 132 bp tandem repeats and meq 
gene of several isolates showed 99% similarity 
to very virulent MDV. According to 
phylogenetic tree and identity, our isolates 
were more similar to very virulent strains of 
China, Egypt, USA, India and Poland.  
The three oncogenic strains confirmed by 
PCR were propagated on cell culture using 
DEF and CEF and were observed daily for 
appearance of CPE within 5-14 dpi. Primary 
propagation on DEF then propagation on CEF, 
CPE appeared within a week dpi. Chick 
embryo fibroblast (CEF) are common cells for 
the production of MD vaccines, but not 
suitable for primary isolation of MDV. The 
CKC or DEF is more suitable cells for primary 
propagation of MDV isolates [18-20]. While, 
CEF can provide an alternative substrate for 
isolation of attenuated strains of MDV-1, also, 
there have been reports of successful 
propagation of MDV in some continuous cell 
lines, such as OU2.2, OU2.1, QM7 and SOgE, 
their use for primary isolation was not 
described [21- 23]. The obtained results of 
MDV isolation on CEF and DEF were 
strengthened by De Laney et al. [24] who 
stated that cell culture isolation could be a 
helpful tool in identification of MDV 
virulence. 
Our virulent MDV field isolates showed 
propagation in cell culture, with the CPE in 
form of small to medium-sized plaques of 
rounded refractile cells or syncytia appearing 
5-8 days post-inoculation. Continuous passage 
of the virus in cell culture leads to its 
adaptation and faster replication in vitro, 
attenuation of the oncogenic potential of the 
virus and structural and gene expression 
changes [25-30]. Attenuated strains produce 
larger plaques and CPE usually occurs 2-4 dpi. 
Conclusion 
In conclusion, although the availability of 
MDV vaccines especially HVT vaccine which 
is used in the examined flocks, the disease was 
recorded. Thus, indicating that HVT vaccines 
are unable to protect completely against more 
virulent strains. Therefore, there is a need to 
develop a new strategy and types of 
vaccination to be able to protect against new 
strains of virus. 
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 الملخص العربي
 عزل وتصنيف عترات شديدة الضراوة من فيروس الماريك من القطعان المحصنة ضد مرض الماريك فى مصر
 1يارا فتحى حسن ،1عبير محمد شاهين ،2سمير عبدالمعز ناصف، 1محمد عبدالعزيز لبدة
 جامعة الزقازيق - كلية الطب البيطرى - قسم طب الطيور والارانب1
 2العباسية – ركزى للرقابة على المستحضرات البيولوجية البيطريةالمعمل الم2
المكثفة ضد  مصرية على الرغم من برامج التحصينالدجاج ال مازال مرض الماريك يمثل مشكلة رئيسية بين قطعان
ت ذا فى اربع واربعين قطيع بياض وامهاتالماريك فيروس . اجريت هذه الدراسة للتحقق فى انتشار عدوى  المرض
قطيع  44من  5102-2102الريش خلال الفترة من بصيلات تم جمع عينات من  شهرا . 02-4اعمار تتراوح بين 
والتى ظهر عليها هزال واورام حشوية وتم اختبار العينات بواسطة اختبار  من قطعان الدجاج المحصنة ضد المرض
  91 LUقطيع ايجابيا ل الماريك باستخدام بريمر  91. وكان البلمرة المتسلسل باستخدام ثلاث ازواج من البريمرات 
بنسبة  taeper mednat pb231و  qemواظهرت ثلاث قطعان ايجابية باستخدام بريمرات . %2.34بنسبة 
يوم بعد  41 -5تجمعات للخلايا خلال  . واظهرت نتائج حقن خلايا الفيبروبلاست من اجنة البط واجنة الدجاج %8.6
للعينات الثلاثة ان السلالات المعزولة اظهرت  taeper mednat pb 231و  qemف التسلسل الجينى ل . وكشالحقن
فى الختام على الهندية والمصرية الشديدة الضراوة . والصينية الأمريكية وتطابق مع المعزولات الاوروبية و %99
فى القطعان التى تم فحصها فى هذه تى تم استخدامه لا  TVHالرغم من توافر لقاحات ضد المرض خصوصا لقاح 
على الحماية الى ان هذه اللقاحات غير قادرة  هذا يشيرالدراسة الا انه تم تسجيل المرض فى هذه الحالات . وبالتالى 
تحصينات لتكون قادرة من ال التامة ضد السلالات الاكثر ضراوة لذلك هناك حاجة لوضع استراتيجية جديدة وانواع
 العترات الجديدة من الفيروس .على الحماية ضد 
 
 
